Korro Bio, Inc.
KRRO · NASDAQ
| Reporting period ended | 12/31/2024 FY 2024 | 12/31/2023 FY 2023 | 12/31/2022 FY 2022 | 12/31/2021 FY 2021 |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $56 | $166 | $37 | $80 |
| Short-Term Investments | $70 | $0 | $19 | $51 |
| Receivables | $2 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $4 | $4 | -$0 | $1 |
| Total Curr. Assets | $132 | $173 | $57 | $135 |
| Property Plant & Equip (Net) | $52 | $43 | $12 | $37 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $37 | $0 | $5 | $13 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $6 | $6 | $0 | $0 |
| Total NC Assets | $95 | $49 | $17 | $51 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $226 | $222 | $74 | $185 |
| Liabilities | – | – | – | – |
| Payables | $4 | $7 | $3 | $3 |
| Short-Term Debt | $0 | $0 | $3 | $3 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $4 | $0 | $0 | $0 |
| Other Curr. Liab. | $4 | $0 | $1 | $2 |
| Total Curr. Liab. | $15 | $19 | $9 | $11 |
| LT Debt | $0 | $0 | $164 | $14 |
| Deferred Rev, NC | $6 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $1 | $1 | $0 | $0 |
| Total NC Liab. | $51 | $32 | $164 | $43 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $45 | $33 | $0 | $29 |
| Total Liabilities | $66 | $52 | $173 | $55 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$267 | -$183 | -$102 | -$180 |
| AOCI | $0 | $0 | -$0 | -$0 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $160 | $170 | -$99 | $131 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $226 | $222 | $74 | $185 |
| Net Debt | -$56 | -$166 | $130 | -$63 |